Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT06262594
Brief Summary:
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Study:
NCT06262594
Study Brief:
Protocol Section:
NCT06262594